Introduction {#S1}
============

The Arabic word *Islam* means peace, purity, and total submission to the will of Allah (the Lord of the worlds, *Rabb al-'alameen*) by conforming inwardly and outwardly to his law. The religion of Islam is based on five pillars (*arkan al-Islam*), and Ramadan fasting is one of these pillars.

In particular, Ramadan fasting represents a particular form of fasting, in that consists of alternate fasting and feasting (re-feeding) periods ([@B1]). Being based on the lunar calendar, mean fasting duration varies depending on the period of the year and the latitude of the place ([@B1], [@B2]).

A number of subjects, including patients, are usually exempted from this duty even though they could be willing to fast for taking part into the atmosphere of this particular moment ([@B3]).

It is a common saying that religion promotes healthy lifestyles. However, the relationship between a religion and cancer has been often overlooked or poorly addressed from a scientific, rigorous point of view ([@B4]), especially in terms of physiology ([@B5]). Among the few studies available in the literature, Mills and collaborators investigated Seventh-Day Adventists. This religious group does not consume tobacco, alcohol, or pork and is characterized by lower cancer-related morbidity rates than the general population, even though the risk for prostate and endometrial cancer was higher ([@B6]). Fraser noticed that non-vegetarian Seventh-Day Adventists were significantly more affected by colorectal and prostate cancer than vegetarian Seven-Day Adventists ([@B7]--[@B9]), as well as of meningioma and glioma ([@B10]). Seventh-Day Adventists present also a particular relationship between cancer risk and allergy ([@B11]). Ogata and coworkers found a lower mortality from respiratory cancers among Zen Buddhists with respect to the general population ([@B12]). Sriplung and collaborators found that a lower incidence of cervical and breast cancers in Muslim than in Buddhist females. Furthermore, they noticed a lower incidence of prostate cancer in Muslim males. Independent of sex and year of diagnosis, the incidence of lung, liver, non-Hodgkin lymphoma (NHL), and colorectal cancers was lower in Muslims ([@B13]). Islamic beliefs can have an impact on access to breast or cervical cancer screening programs and therefore should be carefully taken into account by health workers in the field of Public Health ([@B14]--[@B28]).

The effects of Ramadan fasting on patients suffering from cancer interest physicians in that, in the nowadays globalized society, have to face with issues such as the management of cancer in Muslim patients ([@B29]).

In principle, clinical investigations carried out among patients suffering from cancer fasting during Ramadan could have broad, translational implications. The effects of fasting on cancer have been extensively studied: starvation-induced changes in genome organization, chromatin remodeling, and metabolic pathways modulating, for example, glucose, insulin-growth factor (IGF), and other related enzymes and proteins may increase the effectiveness of chemotherapy ([@B30]--[@B32]). Fasting has an anti-Warburg effect and could have a positive impact on drug pharmacokinetics and could contribute to reduce its side effects, improve the chemotherapeutic index, and overcome at least partially the issue of drug resistance ([@B30]--[@B32]). Furthermore, fasting has a beneficial impact on the renewal of stem cells and on the immune system, in particular on natural killer cells, as well as on the oxidant system, thus enabling cancer growth control ([@B33]--[@B36]). To this respect, different kinds of cancer have been investigated, such as pancreatic ([@B37]), breast ([@B38]--[@B40]), lung ([@B41]), colorectal ([@B42]) and prostate ([@B43]) cancer, and even glioma ([@B44]). The impact of fasting has been assessed on different drugs ([@B45], [@B46]), including irinotecan ([@B47], [@B48]), doxorubicin ([@B49]), and on new recent anti-blastics, such as erlotinib ([@B41]), tyrosine kinase inhibitors ([@B50]), and sirtuin ([@B51]), among others.

Effects of fasting on tumor have been assessed both on neo-adjuvant and adjuvant therapy ([@B40]). Furthermore, fasting seems to sensitize tumor cells and increase the outcome of radiation therapy ([@B44]).

However, despite that this topic has attracted an impressive body of research ([@B52], [@B53]), little is known both in terms of molecular mechanisms and clinical outcomes about the difference among the various existing kinds of fasting, such as periodic diet ([@B54]), calories restriction ([@B55]), dietary restriction ([@B56]) or dietary manipulation ([@B53]), intermittent ([@B38], [@B43], [@B57]) or short-term fasting ([@B40], [@B49]), and prolonged fasting ([@B33], [@B35], [@B39]), among others. Lv and collaborators in a recently published systematic review and meta-analysis concluded that while the roles of ketogenic diet and of caloric restriction in controlling cancer are quite established, evidence of the effectiveness of intermittent fasting is still insufficient ([@B57]). Furthermore, most of these studies have been conducted in animal models; therefore, there is an urgent need for more investigations in human ([@B58]).

Ramadan represents a unique laboratory for studying the effect of fasting in cancer patients, using a multidisciplinary approach. Aspects such as diabetic patients ([@B59]) or with renal ([@B60], [@B61]), infectious ([@B62]), or cardiovascular diseases ([@B63]) have been already reviewed.

However, there is a dearth of information concerning cancer patients willing to fast during Ramadan. For this purpose, we have carried out a systematic review, mining different databases, such as ISI/Web of Science (WoS), MEDLINE/PubMed, Scopus, Scirus, Directory of Open Access Journals (DOAJ), and Google Scholar.

Ramadan and Cancer: Quality of Life and Adherence to Religious Worship {#S2}
======================================================================

Kuzu and collaborators ([@B29]) investigated quality of life and compliance to religious duties (such as praying and fasting) in 178 patients living with a permanent colostomy. Seventy-five underwent abdominoperineal resection (APR, or Miles' operation), 51 sphincter-saving resection, and 52 anterior resection, including sigmoid colectomy. Quality of life was measured with the Medical Outcomes Study Short Form 36 Health Survey (SF-36) and a questionnaire with items about work, sexual life, and compliance to religious worship. They found that a significantly number of patients in the APR group stopped praying daily (either alone or in a mosque) and fasting during Ramadan. They concluded that colorectal cancer, besides affecting quality of life, has a profound impact on religious worship. The authors recommended a preoperative counseling, involving local religious authorities.

Celasin and coworkers ([@B64]) carried out a prospective study recruiting 93 Muslim patients after surgery for colorectal carcinoma: 50 underwent APR, 22 sphincter-saving resection, and 1 anterior resection, including sigmoid colectomy. Quality of life was assessed pre- and postoperatively at 15--18 months with the SF-36 questionnaire and a modified version of the American Society of Colorectal Surgeons (ASCRS) Fecal Incontinence questionnaire. Life standards, including religious practice, were measured using the Ankara University Life Standard Questionnaire (AULSQ). Authors found that religious worship (praying alone, praying in mosques, fasting during Ramadan, and purifying alms) was not significantly different among the groups. Probably, this was the effect of a proper religious counseling and its importance, advocated by Kuzu and collaborators in the previous article ([@B29]), is here confirmed.

Zeeneldin and Taha ([@B65]) conducted a cross-sectional study during Ramadan, August--September 2009, investigating 102 patients suffering from breast cancer (31%), acute leukemia (24%), colorectal cancer (7%), NHL (5%), bladder cancer (4%), lung cancer (4%), and laryngeal cancer (4%). Treatments included chemotherapy, radiotherapy, hormonal therapy, and non-specific therapy in 42, 31, 10, and 17%, respectively. Comorbidities were present in 22% of the patients. Authors found that 40% of patients did not fast during Ramadan, 36 and 24% were partial and complete fasters. Being female patients, having a good and stable performance status, suffering from a non-metastatic solid tumor, and receiving non-intravenous chemotherapy as outpatients were found to be predictor of compliance to fasting. However, only 46% of patients sought the treating oncologist advice on whether they could fast.

Altuntas and coworkers ([@B66]) carried out a prospective study investigating 56 patients with a cancer-related fecal stoma over two periods of Ramadan to analyze the effect of fasting on nutritional and metabolic status and quality of life. Fourteen patients were fasting. They had their stoma for a longer period of time than patients in the non-fasting group, and the proportion of patients with a permanent stoma was higher in the fasting group than in the non-fasting group. Ramadan fasting had almost no influence on quality of life.

Tas and collaborators ([@B67]) performed a survey of 701 adult Turkish Muslim cancer patients during the month of Ramadan in 2012. Before diagnosis of cancer, 93.1% of the patients used to fast completely or partially. After diagnosis of cancer, this rate fell down to 15%: 83.9% of patients who fasted before diagnosis, gave up observing the religious duty. Patients who decided to go on fasting after the diagnosis of cancer thought that observing Ramadan would have lead to Patients who were females, those with good performance status, those without any comorbid disease (in particular, diabetes mellitus), who had non-metastatic disease, those with history of surgery, young, those treated with radiotherapy, and those being treated with single agents, oral chemotherapeutic agents, or not receiving drugs being in the follow-up period were more likely to be fasting than others. The fasting ones suffered from lymphoma, urogenital cancer (in particular, testicular tumor), and breast cancer; conversely, the rate of fasting status among patients with lung and gastrointestinal cancer was quite low. Gynecologic, head and neck, sarcoma, and skin cancers did not correlate with fasting status. Only 20.8% of all patients asked their physician whether it was alright for them to fast and physicians generally had a negative attitude toward fasting (83.2%). About 13.3% of physicians allowed patients to choose whether to fast or not. Physicians were concerned about the possibility of fasting in patients at risk of tumor lysis syndrome, taking nephrotoxic drugs, or other drugs that could lead to vomiting, diarrhea, or renal failure. The authors concluded that majority of cancer patients are not fasting during the month of Ramadan, and a small part of patients consult this situation to their physician.

Ramadan and Cancer: Adherence to Drug Treatment {#S3}
===============================================

Drug compliance during Ramadan generally tends to fall, as noticed by some scholars ([@B68]--[@B70]).

Other authors, such as Zeeneldin and coauthors ([@B71]), however, have found that Ramadan fasting does not impair patient's adherence to treatment. During Ramadan 2010, 139 patients suffering from breast cancer were asked about compliance to fasting and religious duties as well as to treatment with oral hormonal therapy (OHT) in Ramadan and in the preceding month. Tamoxifen and aromatase inhibitors were used in 64 and 36%, respectively. Adherence rates to OHT during Ramadan and before were 94.2 and 95.7%, respectively (not statistically significant). Non-adherence prior to Ramadan and shorter duration of OHT were predictors of non-adherence during Ramadan, while fasting status, age, performance status, presence of metastases, and type of OHT were not good predictors of adherence.

Results and Discussion {#S4}
======================

Despite our extensive search, we managed to find only six studies addressing the issue of patients suffering from cancer fasting during Ramadan: in particular, five focusing on the impact of fasting on quality of life and compliance to worship and one focusing on adherence to drug treatment. Despite the importance and relevance of this topic and given the burden imposed by the cancer, very few scholars have investigated the impact of Ramadan fasting on the health of patients with tumor.

The effect of Ramadan on quality of life appears to be controversial: while three studies confirm this relationship, two other researches fail to find any impact. Also, the effect of fasting on compliance to worship seems to be quite contrasting.

As far as the compliance to drug treatment is concerned, there is only one study available, and therefore it is not possible to collect any evidence.

Conclusion {#S5}
==========

There is a strong need for evidence-based suggestions and guidelines ([@B3]). Very few studies are available, with contrasting findings.

The management of Muslim patients suffering from cancer is very complex and should involve a multidisciplinary team, made up of an oncologist, a nutritionist, a psychiatrist, or a psychologist, who should be aware of the importance of cultural and spiritual beliefs in medicine ([@B5]), and in particular in the oncology practice ([@B72]).

A diagnosis of cancer is always difficult to cope with and in Muslim subjects can have a varying impact, depending also on the degree of religiosity of the subjects itself. Errihani and colleagues found that in practicing Muslims cancer is seen as a divine test and as such accepted, while non-practicing Muslims feel guilty and begin to practice ([@B73]). Therefore, the level of spirituality/religiosity plays a major role in supporting the patient during the health-care process and can influence the clinical outcome. However, as found by the study of Tas and collaborators ([@B67]), the communication between the patient and the physician is not always characterized by an open disclosure and a frank dialog. This is further complicated by the fact that the situation is rather delicate and the doctor, if not culturally competent or sensitive, could be left with dilemmas because of the cultural/religious beliefs and attitudes of the patient ([@B74]).

Oncologists should carefully assess the health conditions of patients and discourage them to fast if they present metastasis or particularly disseminated, aggressive forms of cancer or if they have a history of non-compliance/non-adherence to pharmacological and/or dietary treatment.

On the contrary, patients with a strong motivation to fast should be encourage, in that spirituality/religiosity plays a major role in cancer. The patient feels indeed himself/herself more active being involved in the religious activities, and less depressed and isolated ([@B3]). Furthermore, there is a solid scientific evidence that fasting, activating certain neuroendocrine pathways and leading to the release of neurotrophic factors, can enhance the mood and relieve the pain in patients suffering from chronic disorders ([@B75]).

A particular aspect that should be addressed is the management of terminal patients during Ramadan, especially in terms of terminal nutrition ([@B76]). From the literature, it is known that some Muslim patients with terminal illnesses may express a strong spiritual and religious wish ([@B77], [@B78]). This calls for cooperation between the family and the interdisciplinary palliative care team. On the contrary, some scholars, like Tas and collaborators ([@B67]), have shown that there is poor cooperation between physician and patient. Facing patients' needs is likely to have a great positive impact on the patient's sense of wellbeing.

However, once again, also this topic has been poorly explored, despite the clinical importance of fasting ([@B79]). Therefore, further research in the field is needed.
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